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Sir, Carbapenem resistance among the nosocomial pathogen Klebsiella pneumoniae is increasing worldwide, increasing morbidity, mortality and healthcare costs. 1 Colistin is the drug of choice for treating infections caused by carbapenem-resistant K. pneumoniae (CR-KP); however, its usefulness is threatened by the dissemination of the colistin resistance gene mcr-1.
2 Although clinical isolates of K. pneumoniae with mcr-1 have been sporadically reported, the gene still appears to be relatively rare among the species, [2] [3] [4] particularly among CR-KP, and chromosomally mediated resistance appears to be the most common resistance mechanism.
Le et al. 5 reported that nosocomial infection prevalence in ICUs at three Vietnamese paediatric hospitals was 33%, mostly caused by K. pneumoniae. The CR-KP rate was 55%. To evaluate the prevalence and characteristics of mcr-1-carrying isolates of CR-KP, we collected 205 clinical isolates of CR-KP [determined using the VITEK 2 system (bioMérieux, Marcy-l' Etoile, France)] from February 2015 to September 2016 from 205 patients at one of these hospitals. The isolates were screened for mcr-1 with real-time PCR 2 and three (1.5%) were positive. Two isolates were from tracheal fluid of patients with respiratory failure on the neonatal ICU (taken approximately 4 months apart) and one isolate was from blood of a patient with bronchopneumonia on the ICU (Table 1 ). With the available data, no conclusions on epidemiological links between the patients could be determined.
mcr-1-positive isolates were whole-genome sequenced using the Illumina MiSeq platform (Illumina, San Diego, CA, USA) and reads were uploaded to the Sequence Read Archive (https://www. ncbi.nlm.nih.gov/sra, accession no. SRR5799030-SRR5799032). Average read length was 248 bp and average sequencing depth was 90%. Assembly was performed with SPAdes v.3.1.1 and CLC Genomics Workbench v.9.5.3 (QIAGEN, Hilden, Germany). Antibiotic resistance genes and plasmid associations were queried using the databases at the Center for Genomic Epidemiology (http://www.genomicepidemiology.org/). In addition to mcr-1, the isolates carried a number of resistance genes (Table 1) including aminoglycoside, quinolone, fosfomycin, macrolide, phenicol, sulphonamide and trimethoprim resistance genes, as well as the carbapenemase gene bla OXA-48 carried on the highly transmissible plasmid pOXA-48. 6 For the isolates, mcr-1 was found on 145 307, 188 383 and 189 030 nt long contigs. The contigs had 99% nt similarity to the IncHI2 MDR plasmid pHNSHP45-2 (NCBI accession no. KU341381), which has previously been reported to carry mcr-1 in Escherichia coli.
7 mcr-1 has previously been reported to be carried on IncP plasmids 8 and IncX4 plasmids 4 in K. pneumoniae, indicating that dissemination of mcr-1 among K. pneumoniae is occurring via many different plasmids. An approximately 3688 nt long segment containing ISApl1, mcr-1 and a putative ORF was located approximately 27400 nt downstream of the location in the plasmid reference sequence, in an inverted orientation ( Figure  S1 , available as Supplementary data at JAC Online). This segment, with an additional downstream ISApl1 element, constitutes a composite transposon, hypothesized to be important in mcr-1 mobilization, and the loss of the downstream ISApl1 element may stabilize mcr-1 on the plasmid, facilitating dissemination of the gene. 9 To determine chromosomal colistin resistance determinants, sequences of pmrA, pmrB, pmrC, pmrD, phoP, phoQ, crrA, crrB and mgrB were extracted from the WGS data and evaluated using PROVEAN (http://provean.jcvi.org/index.php). No mutations that were predicted to alter the function of the gene product were detected.
MLST and SNP analysis were performed with CLC Genomics Workbench to evaluate the phylogenetic relationship of the isolates. All isolates were ST307 and the SNP analysis (core genome size: 5166857 bp) indicated a close relationship (maximum difference of 22 SNPs), indicating the possibility of the isolates constituting a single clone.
Hypervirulence was assessed using string tests 10 and querying the BIGSdb database (http://bigsdb.pasteur.fr/) for virulence genes and capsular serotyping. The string tests were negative, genes encoding type 3 fimbriae were the only virulence genes found and the K serotype was 'not defined', indicating that the isolates were not hypervirulent.
MIC determination (Table 1) was performed using Etests (bioMérieux), although MICs of colistin were determined with broth microdilution. Clinical breakpoints were used according to EUCAST (v. 7.1). The isolates were resistant to colistin (MICs between 4 and 8 mg/L) and meropenem (MIC .32 mg/L). The isolates were susceptible only to amikacin, tigecycline and ceftazidime/avibactam, except VN734eta, which was also susceptible to trimethoprim/ sulfamethoxazole.
The finding of clinical isolates of K. pneumoniae harbouring both mcr-1 and bla OXA-48 in a healthcare setting with high rates of nosocomial infections is troubling and emphasizes the need for improved hospital hygiene and prudent use of colistin and carbapenems to prevent further dissemination and emergence of the still rare occurrence of mcr-1 in CR-KP.
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